AnaptysBio Inc (ANAB)
13.97
-0.58
(-3.99%)
USD |
NASDAQ |
Dec 23, 16:00
14.20
+0.23
(+1.65%)
Pre-Market: 08:39
AnaptysBio Free Cash Flow: -103.39M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| SIGA Technologies Inc | 71.46M |
| Candel Therapeutics Inc | -28.69M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.09M |
| Cash from Investing (Quarterly) | 58.62M |
| Cash from Financing (Quarterly) | 71.23M |
| Free Cash Flow Per Share (Quarterly) | -0.3504 |
| Free Cash Flow to Equity (Quarterly) | -10.12M |
| Free Cash Flow to Firm (Quarterly) | -0.036M |
| Free Cash Flow Yield | -27.00% |